Abstract
Enveloped animal viruses fuse their membrane with a host cell membrane in order to deliver their genome into the cytoplasm of the cell and thus initiating infection. This crucial step is mediated by virally encoded transmembrane proteins that, following an appropriate triggering, insert their fusion peptides into the target membrane and, through a cascade of conformational changes, drive the merging of the two apposing membranes. The battle against viruses is ongoing with the constant threat of viruses developing resistance to present drugs and emerging viruses, therefore there is a continuous challenge to improve our defence strategies. Entry inhibitors are currently in development for diverse human and animal viral pathogens, and advances in our understanding on how viral entry proteins undergo conformational changes that lead to entry offer a huge potential for the development of novel therapeutics. This review describes recent advances on viralmediated fusion mechanisms concentrating on the development of peptidic inhibitors of membrane fusion.
Keywords: Membrane fusion, viral fusion peptide, viral inhibitor, heptad repeat, fusion peptide, glycoprotein
Protein & Peptide Letters
Title: Inhibition of Viral-Induced Membrane Fusion by Peptides
Volume: 16 Issue: 7
Author(s): Mariaterasa Vitiello, Marilena Galdiero and Massimiliano Galdiero
Affiliation:
Keywords: Membrane fusion, viral fusion peptide, viral inhibitor, heptad repeat, fusion peptide, glycoprotein
Abstract: Enveloped animal viruses fuse their membrane with a host cell membrane in order to deliver their genome into the cytoplasm of the cell and thus initiating infection. This crucial step is mediated by virally encoded transmembrane proteins that, following an appropriate triggering, insert their fusion peptides into the target membrane and, through a cascade of conformational changes, drive the merging of the two apposing membranes. The battle against viruses is ongoing with the constant threat of viruses developing resistance to present drugs and emerging viruses, therefore there is a continuous challenge to improve our defence strategies. Entry inhibitors are currently in development for diverse human and animal viral pathogens, and advances in our understanding on how viral entry proteins undergo conformational changes that lead to entry offer a huge potential for the development of novel therapeutics. This review describes recent advances on viralmediated fusion mechanisms concentrating on the development of peptidic inhibitors of membrane fusion.
Export Options
About this article
Cite this article as:
Vitiello Mariaterasa, Galdiero Marilena and Galdiero Massimiliano, Inhibition of Viral-Induced Membrane Fusion by Peptides, Protein & Peptide Letters 2009; 16 (7) . https://dx.doi.org/10.2174/092986609788681742
DOI https://dx.doi.org/10.2174/092986609788681742 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Uracils as a Cellular Weapon Against Viruses and Mechanisms of Viral Escape
Current HIV Research Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices
Current Neuropharmacology Emerging β-Amyloid Therapies for the Treatment of Alzheimers Disease
Current Pharmaceutical Design Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Hypertension in Pregnancy: Pathophysiology & Management Strategies
Current Pharmaceutical Design Catatonia: A Narrative Review
Central Nervous System Agents in Medicinal Chemistry Neurological Manifestations of COVID-19 and the Importance of Magnetic Resonance Imaging
CNS & Neurological Disorders - Drug Targets Targeting Purine and Pyrimidine Metabolism in Human Apicomplexan Parasites
Current Drug Targets Dichotomous Life of DNA Binding High Mobility Group Box1 Protein in Human Health and Disease
Current Protein & Peptide Science Neurological Effects of SARS-CoV-2 and Neurotoxicity of Antiviral Drugs Against COVID-19
Mini-Reviews in Medicinal Chemistry Natural Triterpenoids and their Derivatives with Pharmacological Activity Against Neurodegenerative Disorders
Mini-Reviews in Organic Chemistry Heterocycles in the Treatment of Neglected Tropical Diseases
Current Medicinal Chemistry Hypocholesterolemia
Current Vascular Pharmacology Toll-Like Receptor System in the Human Endometrium
Current Immunology Reviews (Discontinued) Neurotrophic Factors in the Pathogenesis of Neurological Disorders with Mental Retardation in Children
Current Pediatric Reviews Novel and Viable Acetylcholinesterase Target Site for Developing Effective and Environmentally Safe Insecticides
Current Drug Targets The Blood-brain Barrier and the Outer Blood-retina Barrier
Medicinal Chemistry Reviews - Online (Discontinued) Adverse Effects and Drug Interactions of Biologic Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Current HIV Research Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis
Current Drug Targets